Sangamo Therapeutics Inc (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -121,122 | -80,447 | -78,939 | -42,974 | -95,419 |
| Depreciation Amortization | 12,544 | 8,361 | 5,281 | 2,453 | 4,899 |
| Accounts receivable | 31,332 | -2,718 | 31,439 | 29,695 | -32,543 |
| Other Working Capital | 252,586 | 227,024 | 202,425 | 15,938 | -73,010 |
| Other Operating Activity | -5,465 | 21,950 | -19,103 | -24,002 | 51,671 |
| Operating Cash Flow | $169,875 | $174,170 | $141,103 | $-18,890 | $-144,402 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -256,209 | -129,963 | 108,259 | 27,495 | -38,864 |
| PPE Investments | -14,714 | -10,703 | -6,694 | -3,775 | -20,675 |
| Purchase Of Investment | -704 | -503 | -237 | N/A | -262 |
| Investing Cash Flow | $-271,627 | $-141,169 | $101,328 | $23,720 | $-59,801 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 153,865 | 146,754 | 145,020 | 820 | 142,451 |
| Other Financing Activity | -765 | -573 | -455 | -411 | -422 |
| Financing Cash Flow | $153,100 | $146,181 | $144,565 | $409 | $142,029 |
| Exchange Rate Effect | -447 | -217 | 19 | 82 | 184 |
| Beginning Cash Position | 81,928 | 81,928 | 81,928 | 81,928 | 143,918 |
| End Cash Position | 132,829 | 260,893 | 468,943 | 87,249 | 81,928 |
| Net Cash Flow | $50,901 | $178,965 | $387,015 | $5,321 | $-61,990 |
| Free Cash Flow | |||||
| Operating Cash Flow | 169,875 | 174,170 | 141,103 | -18,890 | -144,402 |
| Capital Expenditure | -14,714 | -10,703 | -6,694 | -3,775 | -20,675 |
| Free Cash Flow | 155,161 | 163,467 | 134,409 | -22,665 | -165,077 |